Mark Weintraub; Lucia Rodriguez; Margaux Ravis; Eric Wilson; Yuqing Liu/Business InsiderThe pandemic has upended advertising and marketing communications. If clients cut plans, campaigns get canceled, and events can't take place, the implications for agencies and brands are huge.But the need for talent is stronger than ever. Brands that reach consumers at home are thriving. Demand for content remains insatiable. And clients need help to pivot their messaging through unpredictable times.With that in mind, Business Insider has identified 18 top advertising and marketing pros who are on the market right now. The list is based on our own reporting as well as nominations.Some were laid off in the wake of the economic downturn caused by the coronavirus pandemic or lost their jobs in organizational shuffles. Others worked for firms that simply shut down. Another cohort wants to return to agency life after working independently. The list includes agency veterans, C-suite brand executives, and creative talent, like ex WarnerMedia CMO Chris Spadaccini; Alanna Lynch, former CEO of Fake Love; and Ed Gorman, formerly of Carat.Scroll down to read the full list, in alphabetical order by last name.Rodrigo Burdman LinkedIn
The Brazilian-born creative director's career took him from Rio to Sao Paolo to Lisbon to London before landing him in New York. His layoff from marketing powerhouse R/GA came at an odd time, said Rodrigo Burdman — just after winning the D&AD Graphite Pencil Award for Samsung Galaxy A content on TikTok.
The last campaign he oversaw before leaving R/GA promoted Google Play.
"I guess I have the Brazilian heritage for design and making things look nice, no matter what they are," he joked, adding that while he's interested in joining an agency again, "I'm being very cautious."
Steve Chamberlain Steve Chamberlain
A 20-year industry veteran, Steve Chamberlain said he's lived through multiple downturns, but this is the first time he's lost his job.
A VP, director of strategy at DDB Worldwide in Chicago until April, he oversaw the $800 million State Farm account, and had started to reboot branding around Jiffy Lube when pandemic-related layoffs hit. Now Chamberlain is consulting as a brand and creative strategist.
His stints at Mullen, Ideo, and VSA Partners bring experience in design and UX. Chamberlain's also a certified facilitator in human-centered design, which views empathy and problem-solving as key components of design.
Amy Clark LinkedIn
Amy Clark's four-year tenure at MDC-owned The Media Kitchen came to a halt in May, when pandemic-related cuts hit the agency.
She'd risen to the position of associate director, working across clients like Cargill, Lane Bryant, and Vanguard. Clark joined media kitchen as a senior search strategist in 2016; her work bridged digital, content, experiential, and event marketing.
Before The Media Kitchen, Clark spent nearly five years at Media Storm, a planning agency whose clients include media brands themselves. Her pre-advertising experience includes two years as a gallery interpreter at Connecticut's Stepping Stones Children's Museum.
Mike Densmore LinkedIn
A longtime ad pro whose experience includes C-level stints at agencies like Droga5 and Arnold Worldwide, Mike Densmore became New York CEO of Forsman & Bodenfors in 2017. The gig ended in September, when Densmore left the Swedish-born shop with offices in eight countries. Reports also had the MDC-owned agency laying off a chunk of its New York staff.
Now, he's positioning himself as a creative marketer and consultant. Forsman & Densmore's clients have included BMW, Reebok, Uber, and — yes — ABBA.
In February, just before the pandemic wreaked havoc on the industry, Havas Chicago laid off 2.5% of its staff; those cut included group creative directors John Nussbaum and Jon Eckman, along with Adrian Fogel, group director strategy.
A key connector on the Havas team, Fogel has held top-level jobs at Chicago's biggest creative shops, including DDB, Leo Burnett, and WPP's VMLY&R agency, where she was SVP and planning director. Among the clients she's serviced in her most recent role: Cracker Barrel, AutoZone, Orbitz, and Carl's Jr.
At the moment, Fogel is positioning herself as a strategic advisor, offering brand strategy, consumer insights, workshop design, and moderation.
Ed Gorman Ed Gorman
One of the industry's higher-profile casualties, Ed Gorman got cut loose this year as client president of Dentsu Aegis Network's Carat, which bills itself as the No. 1 global media network.
Through a decade-long tenure at the company, he rose from SVP/integrated account director to Carat's top management tier. He'd spent 10 years as Omnicom-owned OMD before that, rising to CMO. At Carat, Gorman was known for creating the Innovation Framework, an approach meant to define and measure innovations.
His career successes included MasterCard's campaign for Stand Up to Cancer, which raised more than $20 million for the cancer charity by redirecting a portion of MasterCard charges.
Britt Hayes LinkedIn
DDB Chicago's April job cuts included top-tier talent like Britt Hayes, the chief people officer/North America. Hayes was in good company with DDB's layoffs; Mark Mulhern, global head of business for megaclient Unilever, was also cut.
As lead recruiter for the creative powerhouse, Hayes came to DDB in 2017 with nearly two decades' experience as a talent matchmaker; she spent a year as executive director of creative management at Grey Group, and nearly six at JWT, where she rose to head of creative talent/worldwide.
Hayes launched her career at McCann in New York, where she spent 12 years as director of creative services.
Digital strategist Megan Herren has pulled no punches about her layoff from creative agency Laundry Service, where — after four promotions in just three years — she worked as a strategist on clients including Converse, Disney, and SGX NYC. She even won a Shorty Award for "Best Media Buying Strategy on a Shoestring Budget" for Freixenet.
Previously, Herren worked as a social media coordinator for Talent Resources, which connects brands like Starbucks, Coca-Cola, and Tide with online influencers.
Alanna Lynch LinkedIn
Since 2019, Alanna Lynch had been CEO of Fake Love, the brand-experience agency acquired by The New York Times Co. in 2016. The Times shut down Fake Love this summer as part of a larger restructuring on the advertising side; while some staffers got reassigned to other divisions, Lynch departed.
Before that, she headed another Times advertising arm, its social storytelling agency Hello Society. Until July 2018, as managing director, Lynch helped lead Chandelier Creative, the multidisciplinary agency whose clients include LVMH Chandon, Google, Coca-Cola, Pepsi, Roc Nation, and Target, Banana Republic.
Tito Melega Tito Melega
After a busy year as a freelancer, longtime creative director Tito Melega longed to return to agency life when the pandemic froze those conversations.
Until January 2019, Melega was chief creative officer of GTB, the agency WPP ran to serve Ford Motor Company across 45 worldwide offices, where he brought together all WPP's creative from around the world.
"We won every award you can imagine for an account that hadn't won an award in ages," he said. "It put them back on the map."
Before that, Melega worked on award-winning campaigns at shops like ChiatDay and BBDO for blue-chip clients like Toyota, ESPN, Holiday Inn, Cisco, and Pepsi. "A lot of people are down on the industry, and rightfully so," he says. "But as creatives, we're solution providers."
Margaux Ravis Margaux Ravis
As an executive producer at Vayner Smart, an arm of holding company Vayner X, Margaux Ravis pushed the boundaries of voice tech as a component of marketing strategy — think Alexa Skills or Google Actions — for clients like NPR and The Shed cultural venue in New York's Hudson Yards.
When VaynerX founder Gary Vaynerchuck killed Vayner Smart early this year, Ravis sought production jobs at other Vayner divisions, but they were filled up. Since then, she's been producing content across platforms for Democratic/progressive causes, but is eager to jump back into agency work.
"I am far more than just a producer," she said. "I think strategically, am great operationally and deeply committed to building happy and teams — all while getting my own hands dirty."
Amber Revoir Amber Revoir
In the seven months since senior recruiter Amber Revoir left Portland, Oregon, digital agency Swift in a pandemic-related layoff, she's turned her experience into a cause.
With two former colleagues, she launched a public Google Sheets document that kept a real-time roster of available talent in the industry. So intense was the attention that the document became TheAvailList, which calls itself "a place for lost talent to be found."
Revoir, in the meantime, has taken on freelance recruiting gigs for indie agencies like Instrument and Mekanism while looking for full-time work at an agency or brand. Before joining Swift in 2017, Revoir was a recruiter for Crispin Porter Bogusky in Denver.
Lucia Rodriguez Lucia Rodriguez
As division director of marketing at Comcast, Lucia Rodriguez bridged advertising strategy, multicultural marketing, internal communications, and outward-facing functions like call centers in the US and Mexico.
"It was about translating marketing strategy and campaigns to a language that all of our distribution channels could understand," said Rodriguez, who also helped lead Unidos, Comcast's Latinx employee resource group.
When Comcast started restructuring in April 2020, Rodriguez applied for other senior positions, but ran up against a hiring freeze. Since then, she's focused on her leadership of Hispanic Unity of Florida, an economic-empowerment organization on whose board she's served since 2016.
Rodriguez's background includes advertising and PR work for clients like Nabisco, Westinghouse, and Toyota in her homeland of Venezuela.
File under ironic timing: Director of integrated production David Rolfe was let go in the April week that BBDO earned 89 short-list slots in the One Show 2020 awards.
According to production-industry trade Shoot, Rolfe and BBDO chief creative officer Greg Hahn both got cut the same day; Hahn promptly launched a US outpost for Canadian ad firm No Fixed Address. The pair had teamed on major BBDO clients including HBO, Bacardi, FedEx, AT&T, GE and Macy's, Shoot said.
Before joining BBDO, Rolfe had been director of integrated production at Crispin Porter+Bogusky, where his work for clients like IKEA, McDonald's, Microsoft, and Coke won multiple awards; at BBDO, he made headlines for hiring stars like Michel Gondry, who directed Fedex's acclaimed "Dreams" spot. Rolfe was also named to the Entertainment Jury at the 2016 Cannes Lions Festival.
Chris Spadaccini Chris Spadaccini.
After just a year as CMO of WarnerMedia entertainment, Chris Spadaccini left the company last month, joining several top execs who have been let go as new WarnerMedia CEO Jason Kilar leaves his mark.
At HBO, where he'd spent two decades, Spadaccini oversaw campaigns for mega, Emmy-winning properties like "Game of Thrones," "Watchmen," and "Succession." Until 1998, Spadaccini worked in VH-1's marketing department; he started his career at celebrity-heavy PR firm PMK/HBH, now known as R&CPMK.
Mark Weintraub Mark Weintraub
At Brooklyn's Huge, where he was managing director, Mark Weintraub helped lead three — well — huge pieces of business in Zelle, Vanguard, and Citrix. Doing double-duty as client services director, he said, he oversaw more than 25 client-service pros across every business in the office.
Since his three-year tenure ended with Huge's COVID-related round of layoffs this spring, Weintraub's been consulting, but open to a full-time assignment.
"I'm looking for a business that has a significant challenge. I'm not looking to be a caretaker," he said.
Before Huge, Weintraub was executive digital group director at Ogilvy & Mather, overseeing the IBM Watson and UPS Global businesses.
Greg Wheeler Greg Wheeler
Associate creative director Greg Wheeler was already working from home when Zimmerman — the Florida-based agency specializing in retail brands — cut his position in April.
In his five years at the firm, Wheeler helped steer campaigns for clients like Johnson & Johnson, Dunkin', and Kay Jewelers, and is known for having a knack for strategy and content. For Firehouse Subs, Wheeler's team "resuscitated a dying brand," he said.
After his layoff, Wilson drove 11,000 miles to Seattle, seeing 15 national parks over two months. "You don't know how the hell this whole thing is going to wash out," said the 25-year ad-industry vet.
Eric Wilson Eric Wilson
After he left Samsung in 2019 as part of a reorg, Eric Wilson took a gig at experiential agency We're Magnetic until a pandemic-related drop in business killed that firm in August.
In his three years at Samsung, he headed brand communication for consumer electronics and home appliances, oversaw multi-million-dollar budgets, leading global product launches, and supervising Samsung's stable of creative agencies.
Before that, Wilson was VP marketing at Time magazine, where he grew its native studio's custom-content business more than 200%.
"I've bounced between agencies and brands, and I think the agency world can easily translate to the brand world," he said. "A lot of brand people just do the status quo. I always think, how do you shake that up while holding up to brand truths? That's the real opportunity."
STOCKHOLM, Oct. 12, 2020 /PRNewswire/ -- Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO) today announces that the Company has informed the European Medicines Agency, EMA, about its intention to submit an application for a conditional marketing authorization of melflufen (INN melphalan flufenamide) in the EU, based on the pivotal phase 2 HORIZON study in relapsed refractory multiple myeloma (RRMM).
The decision to submit an application for conditional approval has been grounded on an in-depth analysis of the regulatory environment and is endorsed by key opinion leaders in the EU. Previously the Company intended to await the results from the ongoing randomized, phase 3 OCEAN study before submitting an application for marketing authorization. Upon completion, the outcome from the OCEAN study comparing melflufen and pomalidomide in patients with RRMM, will be submitted to regulatory authorities to potentially expand the label of melflufen.
The HORIZON study demonstrates that melflufen in combination with dexamethasone has a potential to provide a therapeutic option for patients with RRMM that are hard to treat and have a poor prognosis, including patients with triple-class refractory myeloma and patients with extramedullary disease (EMD).
"Key opinion leaders and clinics across Europe have gained extensive experience of melflufen from our clinical development program in multiple myeloma. We share a mutual interest to enable early access to this rapidly growing patient population in desperate need of new treatment options", says Klaas Bakker, CMO of Oncopeptides.
According to the European Medicines Agency, medicines are eligible for conditional approval if they are aimed at treating or preventing seriously debilitating or life-threatening diseases. Conditional marketing authorizations may be granted if; the benefit-risk balance of the product is positive, comprehensive data can be provided, there is an unmet medical need, and the benefit to public health of making the product available outweighs the risks due to need for additional data.
The US Food and Drug Administration, FDA, has granted priority review to Oncopeptides' New Drug Application of melflufen in combination with dexamethasone for treatment of patients with multiple myeloma. The FDA has set a target date for the review of the New Drug Application, to February 28, 2021.
For more information, please contact:
Klaas BakkerCMO of OncopeptidesE-mail: email@example.com Telephone: +44-7818-523-903
Rein PiirHead of Investor Relations, OncopeptidesE-mail: firstname.lastname@example.org Cell phone: +46-70-853-72-92
The information was submitted for publication on October 12, 2020 at 08:00 (CET).
Melflufen (INN melphalan flufenamide) is a first in class peptide-drug conjugate (PDC) that targets aminopeptidases and rapidly releases alkylating agents into tumor cells. Melflufen is rapidly taken up by myeloma cells due to its high lipophilicity and is immediately hydrolyzed by peptidases to release an entrapped hydrophilic alkylator payload. Aminopeptidases are overexpressed in tumor cells and are even more pronounced in advanced cancers and tumors with a high mutational burden. In vitro, melflufen is 50-fold more potent in myeloma cells than the alkylator payload itself due to the increased intracellular alkylator concentration. Melflufen displays cytotoxic activity against myeloma cell lines resistant to other treatments, including alkylators, and has also demonstrated inhibition of DNA repair induction and angiogenesis in preclinical studies. In the pivotal phase 2 HORIZON study melflufen plus dexamethasone demonstrated encouraging efficacy and a clinically manageable safety profile in heavily pretreated patients with relapsed refractory multiple myeloma, with primarily hematologic Adverse Events (AE) and a low incidence of non-hematologic AEs.
Oncopeptides is a pharmaceutical company focused on the development of targeted therapies for difficult-to-treat hematological diseases. The company is focusing on the development of the lead product candidate melflufen, a first in class peptide-drug conjugate (PDC) that targets aminopeptidases and rapidly releases alkylating agents into tumor cells. Melflufen (INN melphalan flufenamide) is in development as a new treatment for the hematological malignancy multiple myeloma and is currently being tested in multiple clinical studies including the pivotal phase 2 HORIZON study and the ongoing phase 3 OCEAN study. Based on the results from the HORIZON study Oncopeptides has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration, FDA, for accelerated approval of melflufen in combination with dexamethasone for treatment of adult patients with triple-class refractory multiple myeloma. Oncopeptides' global Headquarters is in Stockholm, Sweden and the U.S. Headquarters is situated in Boston, Mass. The company is listed in the Mid Cap segment on Nasdaq Stockholm with the ticker ONCO. More information is available on www.oncopeptides.com.
This information was brought to you by Cision https://news.cision.com
The following files are available for download:
Press release - Oncopeptides moves forward with intent to file for conditional approval of melflufen with EMA